These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 9720464
21. Activity of gatifloxacin compared to those of seven agents against bacteria recovered from outpatients with respiratory tract infection. Smayevsky J, Lopez H, Di Chiara M, Scarano S, Lanza A, Vilches V, Stepanik D, Bantar C, Sucari A. Diagn Microbiol Infect Dis; 2000 Aug; 37(4):261-4. PubMed ID: 10974577 [Abstract] [Full Text] [Related]
22. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Pfaller MA, Ehrhardt AF, Jones RN. Am J Med; 2001 Dec 17; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437 [Abstract] [Full Text] [Related]
23. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. Thornsberry C, Jones ME, Hickey ML, Mauriz Y, Kahn J, Sahm DF. J Antimicrob Chemother; 1999 Dec 17; 44(6):749-59. PubMed ID: 10590275 [Abstract] [Full Text] [Related]
25. Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States. Biedenbach DJ, Jones RN, Pfaller MA, Sentry Participants Group (Americas and Europe). Diagn Microbiol Infect Dis; 2001 Apr 17; 39(4):245-50. PubMed ID: 11404068 [Abstract] [Full Text] [Related]
26. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia. Balkhy HH, Memish ZA, Shibl A, Elbashier A, Osoba A. East Mediterr Health J; 2005 Apr 17; 11(1-2):36-44. PubMed ID: 16532669 [Abstract] [Full Text] [Related]
28. Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. Karlowsky JA, Thornsberry C, Critchley IA, Jones ME, Evangelista AT, Noel GJ, Sahm DF. Antimicrob Agents Chemother; 2003 Jun 17; 47(6):1790-7. PubMed ID: 12760850 [Abstract] [Full Text] [Related]
34. Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project. Marchese A, Debbia EA, Schito GC. J Antimicrob Chemother; 2000 Jul 17; 46 Suppl T1():11-5. PubMed ID: 10997594 [Abstract] [Full Text] [Related]
35. Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance. Boswell FJ, Andrews JM, Jevons G, Wise R. J Antimicrob Chemother; 2002 Oct 17; 50(4):495-502. PubMed ID: 12356793 [Abstract] [Full Text] [Related]
36. [Resistance surveillance of common community respiratory pathogens isolated in China, 2002 - 2003]. Wang H, Yu YS, Liu Y, Li HY, Hu BJ, Sun ZY, Chen MJ. Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar 17; 27(3):155-60. PubMed ID: 15130324 [Abstract] [Full Text] [Related]
37. Moxifloxacin sensitivity of respiratory pathogens in the United Kingdom. Dorai-John T, Thomson CJ, Amyes SG. J Chemother; 2002 Feb 17; 14(1):19-24. PubMed ID: 11892894 [Abstract] [Full Text] [Related]